Assenagon Asset Management S.A. Buys 716,812 Shares of UnitedHealth Group Incorporated $UNH

Assenagon Asset Management S.A. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 121.7% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,306,053 shares of the healthcare conglomerate’s stock after acquiring an additional 716,812 shares during the period. UnitedHealth Group comprises about 0.7% of Assenagon Asset Management S.A.’s portfolio, making the stock its 19th largest holding. Assenagon Asset Management S.A.’s holdings in UnitedHealth Group were worth $542,835,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of UNH. Brighton Jones LLC raised its stake in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its position in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after purchasing an additional 2,324 shares during the period. CMT Capital Markets Trading GmbH bought a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $340,000. Flow Traders U.S. LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $356,000. Finally, Jump Financial LLC bought a new stake in shares of UnitedHealth Group during the second quarter worth approximately $377,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 2.1%

Shares of NYSE:UNH opened at $403.94 on Friday. The business has a fifty day simple moving average of $413.55 and a 200 day simple moving average of $350.44. UnitedHealth Group Incorporated has a 12-month low of $239.50 and a 12-month high of $461.62. The firm has a market cap of $366.84 billion, a P/E ratio of 25.99, a P/E/G ratio of 1.43 and a beta of 0.62. The company has a quick ratio of 0.80, a current ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The business had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Analysts predict that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th were paid a $2.32 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.3%. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio (DPR) is presently 59.72%.

Analyst Ratings Changes

Several research firms have weighed in on UNH. DA Davidson set a $512.00 price objective on UnitedHealth Group in a research report on Tuesday, July 21st. Truist Financial raised their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 target price on the stock in a research report on Wednesday, April 22nd. HSBC increased their price target on UnitedHealth Group from $300.00 to $380.00 and gave the stock a “hold” rating in a research report on Monday, July 6th. Finally, Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $455.92.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.